[Elsevier] Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial

Pandisan Post time Yesterday 23:03 | Show all posts |Read mode

This post will be closed automatically in 2026-09-18 23:01

Reward10points

Journal: Elsevier

Authors: : Daisuke Yabe 1,Toshihiko Shiraiwa 2,Hiroyuki Ugai 3,Masakazu Takeuchi 4,Ryo Suzuki 5

Published: October, 2026

DOI: https://doi.org/10.1016/s2213-8587(26)00138-5

Article Link: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(26)00138-5/abstract

Remark: Please help me find this paper :)

Reply

All Reply0 Show all posts

Pandisan Lv.3

Intermediate member

[Elsevier] Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial Copy